Peer Review History
| Original SubmissionJuly 5, 2019 |
|---|
|
PONE-D-19-18880 A low-cost fluorescence reader for in vitro transcription and nucleic acid detection with Cas13a PLOS ONE Dear Dr. Heymann, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please consider all the points of the reviewers, including a limit of detection assay and controls. Detecting a real sample is not absolutely required. We would appreciate receiving your revised manuscript by Sep 13 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Mark Isalan Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating the following in your Competing Interests section: [none]. Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now * This information should be included in your cover letter; we will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Summary This manuscript describes the development of a low-cost fluorescence spectrophotometer designed to facilitate fluorescence measurements at the point-of-care. The authors have presented a very clever and resourceful design for a fluorescence detector. Given the growing interest in point-of-care diagnostics, I think that this work will be of broad interest to the synthetic biology and biotechnology community. As such, I think this piece is well suited for PLoS One and recommend that this manuscript be published after a few major and minor revisions, explained in detail below. Major revisions The authors argue that their fluorescence detector can be used in low-resource settings, but it appears that operation of the detector requires software run on an external computer, which may not be available. Could the software instead be run on a smart phone or tablet? If so, I recommend including this as a demonstration in the manuscript to support the claim that the detector can be used in low-resource settings. Broadly, I ask that the authors somehow address this issue of portability and accessibility before claims about utility in low-resource settings can be made. The authors argue in their abstract that DIY construction of their fluorescence detector could serve as an educational activity that combines electrical engineering, computer engineering, and biochemistry concepts. However, no framework or target audience (high school, undergraduate, etc.) for teaching such concepts is discussed. Please either provide example curriculum pieces (powerpoint, worksheets, etc.) to support this claim or remove it from the manuscript. In the results section, I would have liked to read more about the rationale and strategy behind the development of the spectrophotometer. How did you design the device? Did you deconstruct high-tech equipment or model after existing low-cost fluorescence detection equipment? I’d imagine some of the choices made, such as the use of photography lighting filters instead of expensive scientific light filters, might not have been tried before and would be of interest to others seeking to replicate or expand upon this work. Since the design of the fluorescence spectrometer is the crux of this work, I recommend that the authors add discussion of their detector design strategy placing it in the context of previous efforts. Minor revisions A low-cost fluorescence imager designed to enable qualitative or semi-quantitative analysis of cell-free reactions as part of hands-on educational activities was recently described (https://advances.sciencemag.org/content/4/8/eaat5107). Please include this citation in the discussion when educational applications are discussed. I noticed on the order of 10 typos throughout the manuscript - please address before resubmission. Reviewer #2: This study (by Katzmeier, Aufinger, Dupen, Quinteiro et al.) develops a low-cost fluorescence reader, and demonstrate applications with Cas13 detection of RNA, and the RNA aptamer Spinach. I think the technology described has promise, but would like to see additional validation to show the sensitivity of Cas13 detection using the device for readout, as well as a few additional controls to validate the performance. With these additions, the paper should be suitable for publication. Major comments: 1. Does the cartridge need to be cleaned in between uses? It is unclear if any sample from the filter paper might be carried over between runs. The authors should clarify this point, as it influences the utility of the device. 2. The authors should perform a limit of detection assay using Cas13a and their fluorescent detector, if they want to use Cas13 as an application of their device. It is not sufficient to show a single experiment, with 100 nM target, and make claims in the abstract about detection in the "nanomolar range". 3. Similarly, Table 1 is misleading, as the fluorescein calibration experiments (shown in Fig. 4) appear to be independent of Cas13 - as far as I can tell no sensitivity analysis has been performed with Cas13 (just with fluorescein). 4. Figure 6b does not have any negative controls, please rerun this experiment with some negative controls (or show them in the plot). Minor comments: 1. Some of the figures could be combined to improve clarity (e.g., 3 and 4; possibly 1 and 2) 2. What is the final concentration of Cas13a and crRNA in the detection reactions? It is unclear (as written) in the Methods section. 3. The fluorescence in the presence of noncognate target is increasing over time in panel 7c and 7d, to approximately 1/3 of the maximum signal detected for Cas13 in the presence of cognate target after 1 hour of detection. This is remarkably high. Can the authors comment on why this is the case? Is there some sort of impurity present in the Cas13 or crRNA? This effect does not appear to be specific to the detector system being used, so presumably is coming from one of the reagents. 4. There appears to be a broken reference (a "?" in line 72). Please fix, and proofread the manuscript to ensure that no other such typos are present. 5. The authors reference several point of care technologies, but have omitted a recent demonstration of Cas13 detection of viruses at the point of care, which was published alongside the SHERLOCK 2.0 paper: doi: 10.1126/science.aas8836 Reviewer #3: In this manuscript, the authors developed a low-cost fluorescence reader for POCT application. With the employment of the CRIPSR-Cas13 collateral cleavage activity against RNA, target RNA can be conveniently detected by the developed reader with high sensitivity. And this invent surely has the potential to be widely used in both clinical and household application scenarios. I have only several minor concerns for the authors to address before the work can be accepted for publication. 1) The filters can be polluted by the paper strip. How to avoid the pollution? 2) In figure 7, longer reaction time is required for the detector, and the authors proposed several possibilities. However, it is still highly recommended that the authors may test with increased amount of enzyme with the detector. 3) To demonstrate the practicability of the device and the system, the authors may need to detect a real clinical or nonclinical sample with the system. 4) Besides of Cas13, Cas12 has also been used for CRISPR-Dx (i.e. HOLMES and DETECTR), and the authors may need to discuss them or at least describe in the introduction part. If the reader is also compatible with the Cas12 system, more readers will be interested. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
A low-cost fluorescence reader for in vitro transcription and nucleic acid detection with Cas13a PONE-D-19-18880R1 Dear Dr. Heymann, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Please note one outstanding point from Reviewer #2, which should be amended at this final submission stage: "One key component is still missing: the make, model, and settings used to acquire fluorescence data with the plate reader. This will allow the reader to more easily interpret and compare results between the author's device and a more standard setup, and is important for reproducibility." Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Mark Isalan Section Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes Reviewer #3: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have very satisfactorily addressed all of my concerns from the initial round of review. I recommend to accept the revised manuscript. Reviewer #2: The authors have addressed nearly all of my comments. One key component is still missing: the make, model, and settings used to acquire fluorescence data with the plate reader. This will allow the reader to more easily interpret and compare results between the author's device and a more standard setup, and is important for reproducibility. Reviewer #3: The revised manuscript has been much improved and all of my previous concerns have been fully addressed. Considering the fierce competition in the field of CRISPR diagnostics, this referee suggests that this work should be accepted for publishing on PLOS ONE without much delay. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No |
| Formally Accepted |
|
PONE-D-19-18880R1 A low-cost fluorescence reader for in vitro transcription and nucleic acid detection with Cas13a Dear Dr. Heymann: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Mark Isalan Section Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .